Merck renews commitment to Bionomics MS partnership
26 May, 2010 by David BinningAdelaide-based biotech Bionomics has announced that its partnership with Merck Serono to develop treatments for MS and other autoimmune diseases has been extended by a year.
Garvan’s head cancer researcher honoured
24 May, 2010 by Staff WritersProfessor Rob Sutherland is this year’s recipient of the NSW Premier’s Award for Outstanding Cancer Researcher.
Feature: Brains and brawn of endocytosis
24 May, 2010 by Fiona WylieThe plasma membrane is like border security for a eukaryotic cell, and we all know how important border security is, especially in an election year. Nothing gets in or out without passing across this specialised lipid bilayer, although for Professor Sandra Schmid from the Scripps Research Institute in La Jolla, California, ‘in’ is the only direction that matters.
Trial application made for promising melanoma treatment
24 May, 2010 by David BinningPatrys Limited announced today that it has applied for approval to start human clinical trials testing its PAT-SM6 natural human antibody product on Australian melanoma melanoma patients.
Biotechnology profile: Bright future for Clinuvel (ASX:CUV)
03 May, 2010 by Tim DeanAustralia has a mixed relationship with the sun. We all know that exposure to sunlight can be damaging, with melanoma of the skin being the fourth most prevalent cancer in this country. Yet even with the known threat, many Australians find themselves drawn to basking in the rays of the sun in the hope of cultivating a deep and lustrous tan.
Twin study shows MS is more nurture than nature
29 April, 2010 by Tim DeanMonozygotic - or identical - twins have provided science with the ideal platform for distinguishing between genetic and environmental influences for anything from personality, risk of cardiovascular disease or even voting habits.
Link between weight loss and immune function
20 April, 2010 by Tim DeanOver half the Australian population is either overweight or obese, with many experiencing corresponding health effects, such as cardiovascular disease and Type 2 diabetes.
Global cancer genome project releases first data
15 April, 2010 by Tim DeanAustralian researchers release initial pancreatic cancer genomes as part of the International Cancer Genome Consortium.
Gene linked to breast cancer survival
14 April, 2010 by Tim DeanA gene associated with eye colour and skin pigmentation has been linked to survival rates in breast cancer patients.
Breast cancer linked to stem cells
12 April, 2010 by Tim DeanThe mechanism linking breast cancer to stem cells has been uncovered, which could lead to new cancer treatments.
Potential new Alzheimer's drugs advancing in clinical trials
08 April, 2010 by Staff WritersThe hypothesis that amyloid-beta blockers is the cause of Alzheimer's disease is being put to the test.
Phosphagenics goes global
31 March, 2010 by Staff WritersPhosphagenics signs global agreement for use of transdermal insulin in pets.
Insight in to insulin could lead to new diabetes treatment
24 March, 2010 by Tim DeanStructure of a previously unseen part of the insulin receptor has been revealed by WEHI scientists.
Coeliac disease related to diabetes
22 March, 2010 by Staff WritersAn international research team has identified new gene variants associated with gluten intolerance.
Positive results for Specialised Therapeutics Australia in lung cancer trial
18 March, 2010 by Tim DeanPhase III trial shows breast cancer drug, Abraxane, effective against lung cancer.
